Imaging of nodal metastases in the head and neck

被引:52
作者
Anzai, Y
Brunberg, JA
Lufkin, RB
机构
[1] Department of Radiology, University of Michigan Hospital, Ann Arbor, MI 48109-0030
[2] Department of Radiological Sciences, University of California, Los Angeles, CA
关键词
head and neck neoplasm; lymphatic system; nodal metastasis; magnetic resonance imaging; iron oxide; positron emission tomography;
D O I
10.1002/jmri.1880070503
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Therapeutic outcome of head and neck cancer is influenced strongly by the presence of nodal metastases. Sensitivity and specificity of the physical examination for the diagnosis of nodal metastasis is unsatisfactory, resulting in both false negatives and false positives of 25 to 40%. Preoperative detection of nodal metastases therefore becomes one of the important goals of imaging studies of patients with head and neck cancer. Despite several advanced techniques and the wide clinical use of MR. MR has surprisingly added little to the diagnostic accuracy of contrast-enhanced CT, Although CT and MR allow detection of abnormally enlarged nodes or necrotic nodes, neither borderline-sized nodes without necrosis nor extracapsular spread are reliably differentiated from reactive or normal nodes in patients with head and neck cancer. Lack of definitive diagnostic methods of metastatic lymph nodes is a serious shortcoming in the preoperative workup far patients with head and neck cancer. To avoid missing small metastatic nodes, a large number of patients clinically staged as NO have undergone elective neck dissection to exclude metastases. With development of more tissue-specific imaging techniques, patients can be better characterized according to the status of nodal disease so that an appropriate therapeutic protocol can be designed. for an individual case.
引用
收藏
页码:774 / 783
页数:10
相关论文
共 72 条
[1]  
ANZAI Y, 1992, AM J NEURORADIOL, V13, P879
[2]   INITIAL CLINICAL-EXPERIENCE WITH DEXTRAN-COATED SUPERPARAMAGNETIC IRON-OXIDE FOR DETECTION OF LYMPH-NODE METASTASES IN PATIENTS WITH HEAD AND NECK-CANCER [J].
ANZAI, Y ;
BLACKWELL, KE ;
HIRSCHOWITZ, SL ;
ROGERS, JW ;
SATO, Y ;
YUH, WTC ;
RUNGE, VM ;
MORRIS, MR ;
MCLACHLAN, SJ ;
LUFKIN, RB .
RADIOLOGY, 1994, 192 (03) :709-715
[3]  
ANZAI Y, 1994, AM J NEURORADIOL, V15, P87
[4]   MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent [J].
Anzai, Y ;
Prince, MR ;
Chenevert, TL ;
Maki, JH ;
Londy, F ;
London, M ;
McLachlan, SJ .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (01) :209-214
[5]   Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses [J].
Anzai, Y ;
Carroll, WR ;
Quint, DJ ;
Bradford, CR ;
Minoshima, S ;
Wolf, GT ;
Wahl, RL .
RADIOLOGY, 1996, 200 (01) :135-141
[6]  
ANZAI Y, 1994, CLIN EXPERIENCE FDG
[7]   THE USE OF POSITRON EMISSION TOMOGRAPHY FOR EARLY DETECTION OF RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA IN POSTRADIOTHERAPY PATIENTS [J].
BAILET, JW ;
SERCARZ, JA ;
ABEMAYOR, E ;
ANZAI, Y ;
LUFKIN, RB ;
HOH, CK .
LARYNGOSCOPE, 1995, 105 (02) :135-139
[8]   ORBIT, SKULL BASE, AND PHARYNX - CONTRAST-ENHANCED FAT SUPPRESSION MR IMAGING [J].
BARAKOS, JA ;
DILLON, WP ;
CHEW, WM .
RADIOLOGY, 1991, 179 (01) :191-198
[9]  
Batsakis JG, 1979, TUMORS HEAD NECK, P240
[10]   PILOT-STUDY OF POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER RECEIVING RADIOTHERAPY AND CHEMOTHERAPY [J].
BERLANGIERI, SU ;
BRIZEL, DM ;
SCHER, RL ;
SCHIFTER, T ;
HAWK, TC ;
HAMBLEN, S ;
COLEMAN, RE ;
HOFFMAN, JM .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1994, 16 (04) :340-346